Literature DB >> 26865580

PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations.

T Helleday1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26865580     DOI: 10.1093/annonc/mdw048

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  18 in total

1.  New Quantitative Mass Spectrometry Approaches Reveal Different ADP-ribosylation Phases Dependent On the Levels of Oxidative Stress.

Authors:  Vera Bilan; Nathalie Selevsek; Hans A V Kistemaker; Jeannette Abplanalp; Roxane Feurer; Dmitri V Filippov; Michael O Hottiger
Journal:  Mol Cell Proteomics       Date:  2017-03-21       Impact factor: 5.911

Review 2.  PARP Inhibitors in Prostate Cancer.

Authors:  Praveen Ramakrishnan Geethakumari; Matthew J Schiewer; Karen E Knudsen; Wm Kevin Kelly
Journal:  Curr Treat Options Oncol       Date:  2017-06

3.  Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.

Authors:  Gábor Rubovszky; Barna Budai; Erna Ganofszky; Zsolt Horváth; Éva Juhos; Balázs Madaras; Tünde Nagy; Eszter Szabó; Tamás Pintér; Erika Tóth; Péter Nagy; István Láng; Erika Hitre
Journal:  Pathol Oncol Res       Date:  2017-04-29       Impact factor: 3.201

Review 4.  Targeting DNA repair and replication stress in the treatment of ovarian cancer.

Authors:  Junko Murai
Journal:  Int J Clin Oncol       Date:  2017-06-22       Impact factor: 3.402

5.  An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer.

Authors:  Guian Zhang; Yong Luo
Journal:  Int J Gen Med       Date:  2021-11-30

6.  Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating Mutation.

Authors:  Wei Zhang; Junping Shi; Rentao Li; Zhiqiang Han; Ling Li; Guanghao Li; Bo Yang; Qiang Yin; Yingying Wang; Yan Ke; Qiang Li
Journal:  Oncologist       Date:  2020-02-11

7.  Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?

Authors:  Hanan Goldberg; Liat Shavit Grievink; Roy Mano; Yaara Ber; Rachely Ozalbo; Sivan Tuval; Jack Baniel; David Margel
Journal:  Oncotarget       Date:  2017-10-10

Review 8.  Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer.

Authors:  Vipul Bhatia; Bushra Ateeq
Journal:  Trends Mol Med       Date:  2019-07-25       Impact factor: 11.951

Review 9.  Base excision repair of oxidative DNA damage: from mechanism to disease.

Authors:  Amy M Whitaker; Matthew A Schaich; Mallory R Smith; Tony S Flynn; Bret D Freudenthal
Journal:  Front Biosci (Landmark Ed)       Date:  2017-03-01

Review 10.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.